Results 321 to 330 of about 5,337,944 (374)

Advancements in artificial intelligence for ultrasound diagnosis of ovarian cancer: a comprehensive review. [PDF]

Front Oncol
Tang C, Xu Z, Duan H, Zhang S.
europepmc   +1 more source

Intermediate Filament Protein BFSP1 Maintains Oocyte Asymmetric Division by Modulating Spindle Length

Advanced Science, EarlyView.
Different from mitosis, the female meiosis undergoes asymmetric division that produces haploid oocytes and polar body, which is essential for retaining maternal components to support subsequent fertilization and embryo development. However, the underlying mechanisms are still largely unknown.
Yu Li, Hanwen Zhang, Wenjun Zeng, Yilong Miao, Shaochen Sun, Yu Zhang, Bo Xiong   +6 more
wiley   +1 more source

Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer. [PDF]

Front Pharmacol
Tessarollo NG, Guimarães IDS, Dos Santos DZ, Henriques TB, Lyra-Junior PCM, Carlos de Souza J, Pimenta TM, Martins BDS, Butzene SMS, Padilha JMS, Maciel LLF, Almeida JCA, Silva IV, Rangel LBA.   +13 more
europepmc   +1 more source

Exosomal CMTM4 Induces Immunosuppressive Macrophages to Promote Ovarian Cancer Progression and Attenuate Anti‐PD‐1 Immunotherapy

Advanced Science, EarlyView.
In ovarian tumors with high CMTM4 expression, exosomes transfer CMTM4 to macrophages, upregulating ICAM1 and promoting M2 polarization via p65 nuclear translocation. This suppresses immunity by increasing PD‐1 and Tregs while reducing CD8+ T cells.
Bo Yin, Jianyi Ding, Jie Liu, Haoran Hu, Yashi Zhu, Meiqin Yang, Huijuan Zhou, Baoyou Huang, Tiefeng Huang, Mengjie Li, Yinyan He, Ang Li, Lingfei Han   +12 more
wiley   +1 more source

Promoting equitable genetic testing in ovarian cancer: the demonstration of improvement for molecular ovarian cancer testing (DEMO) project. [PDF]

BMJ Open Qual
Leung EY, Funingana IG, Bird L, Alcaraz ML, Evans A, Considine A, Freeman S, Jimenez-Linan M, Spencer C, Phanasan K, Winning J, Ang JE, Parkinson C, Ong KR, Butler S, Ridgway O, Charles I, Pannell R, Abedin P, Boyle W, Emery J, Salter-Scott J, Williams S, Ganesan R, Sundar S, Balega J, Brenton JD.   +26 more
europepmc   +1 more source

Visualization of the Spiral Ganglion Neuron in Vivo Using a Novel 177Lu Nuclear Molecule Label

Advanced Science, EarlyView.
The study developed and validated a radionuclide‐labeled anti‐VGLUT1 antibody probe for the first nuclear imaging of cochlear spiral ganglion neurons (SGNs) in vivo. This approach may provide aid in screening candidates suitable for CI surgery by quantifying the number of surviving SGNs, and predicting the potential for postoperative hearing ...
Chenyang Kong, Xiaohui Wang, Jintao Yu, Li Wen, Chengwen Zheng, Ge Yin, Kai Xu, Weiwei He, Hao Wang, Xiaoli Lan, Dawei Jiang, Yu Sun   +11 more
wiley   +1 more source

WDR62 affects the progression of ovarian cancer by regulating the cell cycle. [PDF]

Hereditas
Yang Y, Jing W, Zhang L, Zhang Y, Shang Y, Kuang Y.   +5 more
europepmc   +1 more source

O‐GalNAc Glycosylation Activates MBL‐Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis

Advanced Science, EarlyView.
Upregulated glycosyltransferase GALNT9 in neuroendocrine (NE) carcinomas increases O‐GalNAc glycosylation on cell membrane proteins, particularly Annexin‐A2 (ANXA2). Elevated O‐GalNAc glycan induces the binding of NE cancer cells to mannose binding lectin 2 (MBL2), activating the MBL‐MBL associated serine protease (MBL‐MASP) complement pathway in the ...
Xinyu Chen, Wei Bao, Kaiyuan Liu, Na Jing, Genyu Du, Luyao Jiang, Qian You, Yingchao Zhang, Penghui Xu, Chaping Cheng, Nan Wang, Xialian Xi, Mingyue Wang, Yiyun Liu, Jinming Wang, Huifang Zhao, Shilei Zhang, Dinglan Wu, Chi‐Fai Ng, Jiahua Pan, Wei Xue, Wei‐Qiang Gao, Pengcheng Zhang, Kai Zhang, Helen He Zhu   +24 more
wiley   +1 more source

A Wearable In‐Pad Diagnostic for the Detection of Disease Biomarkers in Menstruation Blood

Advanced Science, EarlyView.
MenstruAI integrates a paper‐based biosensor into sanitary pads to detect biomarkers in menstrual blood, enabling accessible, lab‐free diagnostics health. The platform supports early disease detection, especially in underserved communities, while challenging menstrual stigma and opening pathways for scalable, inclusive, and sustainable population ...
Lucas Dosnon, Thomas Rduch, Charlotte Meyer, Inge K. Herrmann   +3 more
wiley   +1 more source